Here's why BT Investment Management Ltd soared 7%

BT Investment Management Ltd (ASX:BTT) have hit a new all-time high.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors reacted positively to the full year profit result announcement by the Westpac Banking Corp (ASX: WBC) aligned fund manager and financial service provider BT Investment Management Ltd (ASX: BTT)  yesterday, sending the share price up 7.4% to finish the trading session at $11.35 which marked a record all-time closing high.

The stock has now gained a massive 88.5% in the past 12 months, putting the performance well ahead of peer IOOF Holdings Limited (ASX: IFL) which has returned 2.5% and the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) which is down 5%.

Result Highlights

  • BT delivered a record result with a cash net profit after tax of $132.5 million, equating to 44 cents per share (cps)
  • Dividends grew 6% to 37 cps
  • The group reported a 28% rise in base management fees
  • Net inflows of $5.7 billion were recorded taking total funds under management (FUM) to $78.4 billion
  • Investment performance across BT's funds was strong with 97% of FUM exceeding respective benchmarks over three years and 99% exceeding benchmark over five years.

Outlook

While no specific guidance was given, management noted that the current FUM level is higher than the average level across the past financial year; that investment performance remained strong with a number of funds producing strong outperformance and performance fees currently accrued of $85.1 million; and that good FUM momentum had continued into the current year.

With the stock trading on a historic price-to-earnings ratio and dividend yield of around 25.8x and 3.2%, arguably the current share price of $11.35 accurately reflects the positive performance and outlook for the group.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »